Skip to main content
. 2016 Oct 18;4:110. doi: 10.3389/fcell.2016.00110

Table 2.

Pathophysiological roles of FGFs in the postnatal mouse heart.

Function Heart phenotype
PARACRINE SIGNAL
FGF2 Loss-of-function Protection against induced cardiac hypertrophy and fibrosis Promotion of cardiac ischemia-reperfusion injury
Gain-of-function Promotion of cardiac hypertrophy
FGF9 Gain-of-function Improvement in heart function
Gain-of-function Protection against heart injury
FGF10 Gain-of-function Protection against heart injury
Gain-of-function Promotion of cardiomyocyte proliferation
FGF16 Loss-of-function Promotion of induced cardiac hypertrophy and fibrosis
FGF21 Loss-of-function Promotion of induced cardiac hypertrophy and inflammation
ENDOCRINE SIGNAL
FGF21 Gain-of-function Protection against cardiac dysfunction and inflammation
Loss-of-function Promotion of cardiac dysfunction and inflammation
HHS Vulnerability Disclosure